- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
/index.php?option=com_iwpfile&file=/dir_01/he2002_1128.pdf
The Department of Defense is praising FDA's approval of BioPort's new manufacturing facility to produce anthrax vaccine. DOD expects an announcement regarding its anthrax vaccination policy in the near future.
/index.php?option=com_iwpfile&file=/dir_01/he2002_1125.pdf
Using funds from legislation signed into law Jan. 10, HHS announces it will provide states with $1.1 billion for bioterrorism-related efforts.